title: Angiomodulatory and neurological effects of ginsenosides.
abstract: Panax ginseng C.A. Meyer, one of the most popular and valued herbs, has been used extensively in traditional Chinese medicine for thousands of years. More than thirty ginsenosides, the pharmacologically active ingredients in ginseng, have been identified with various sugar moieties attached at the C-3, C-6 and C-20 positions of the steroidal skeleton. We herein review the current literature on the pharmacological effects of ginsenosides on the modulation of angiogenesis, dysregulations of which contribute towards many pathological conditions. Regarding the adaptogenic property of ginseng, the effects of ginsenosides on central nervous system are also discussed. Recent researches have pointed to the steroid hormone receptors as the target molecules to elicit the diverse cellular and physiological activities of ginseng. We believe that understanding the interaction between ginsenosides and various steroid hormone receptors may provide clues to unravel the secret of ginseng.
authors.affiliation: Department of Biology, Hong Kong Baptist University, Kowloon Tong, Hong Kong.
authors.forename: K W
authors.initials: KW
authors.lastname: Leung
authors.forename: K K L
authors.initials: KK
authors.lastname: Yung
authors.forename: N K
authors.initials: NK
authors.lastname: Mak
authors.forename: P Y K
authors.initials: PY
authors.lastname: Yue
authors.forename: H-B
authors.initials: HB
authors.lastname: Luo
authors.forename: Y-K
authors.initials: YK
authors.lastname: Cheng
authors.forename: T P D
authors.initials: TP
authors.lastname: Fan
authors.forename: H W
authors.initials: HW
authors.lastname: Yeung
authors.forename: T B
authors.initials: TB
authors.lastname: Ng
authors.forename: R N S
authors.initials: RN
authors.lastname: Wong
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D003071:Cognition / Q000187:drug effects; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects; D036145:Ginsenosides / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008958:Models, Molecular; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D019636:Neurodegenerative Diseases / Q000188:drug therapy; D018696:Neuroprotective Agents / Q000494:pharmacology*
chemical_list: D020533:Angiogenesis Inhibitors; D036145:Ginsenosides; D018696:Neuroprotective Agents